• 1
    National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cancer-related Fatigue. Version 1.2007. Available at URL: Accessed February 1, 2007.
  • 2
    Andrews P,Morrow G,Hickok J,Roscoe J,Stone P. Mechanisms and models of fatigue associated with cancer: evidence of preclinical and clinical studies. In: ArmesJ,KrishnasamyM,HigginsonIJ, eds. Fatigue in Cancer. Oxford, United Kingdom: Oxford University Press; 2004: 5187.
  • 3
    Servaes P,Verhagen C,Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002; 38: 2743.
  • 4
    Stone P,Richardson A,Ream E,Smith AG,Kerr DJ,Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Ann Oncol. 2000; 11: 971975.
  • 5
    Vogelzang NJ,Breitbart W,Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol. 1997; 34: 412.
  • 6
    Carr D,Goudas L,Lawrence D, et al. Management of Cancer Symptoms: Pain, Depression and Fatigue. Evidence Report/Technology Assessment no. 61. AHRQ Publication no. 02-E032. Rockville, Md: Agency for Healthcare Research and Quality; 2002.
  • 7
    Markes M,Brockow T,Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2006; CD005001.
  • 8
    Barsevick AM,Dudley W,Beck S,Sweeney C,Whitmer K,Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004; 100: 13021310.
  • 9
    Ream E,Richardson A,Alexander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial. J Pain Symp Manage. 2006; 31: 148161.
  • 10
    Sharpe M,Hawton K,Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. Br Med J. 1996; 312: 2226.
  • 11
    Deale A,Chalder T,Marks I,Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomised controlled trial. Am J Psychiatry. 1997; 153: 408414.
  • 12
    Prins JB,Bleijenberg G,Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001; 357: 841847.
  • 13
    Lethem J,Slade PD,Troup JD,Bentley G. Outline of a fear-avoidance model of exaggerated pain perception—I. Behav Res Ther. 1983; 21: 401408.
  • 14
    Philips HC. Avoidance behaviour and its role in sustaining chronic pain. Behav Res Ther. 1987; 4: 273279,
  • 15
    Philips HC. The effects of behavioural treatment on chronic pain. Behav Res Ther. 1987; 25: 365377.
  • 16
    Chalder T,Butler S,Wessely S. In-patient treatment for chronic fatigue syndrome. Behav Psychother. 1996; 24: 351365.
  • 17
    Portenoy RK,Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999; 4: 110.
  • 18
    Oken MM,Creech RH,Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5: 649655.
  • 19
    Taves DR. Minimisation: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974; 15: 443453.
  • 20
    Godfrey E,Chalder T,Ridsdale L, et al. Investigating the ‘active ingredients’ of cognitive behavioural therapy and counselling for patients with chronic fatigue in primary care: developing a new process measure to assess treatment fidelity and predict outcome. Br J Clin Psychol. In press.
  • 21
    Fitzpatrick R,Davey C,Buxton MJ,Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998; 2: 14,1–74.
  • 22
    Aaronson NK. The EORTC-QLQ-30: a quality of life instrument for use in international clinical trials in oncology. [abstract]. Qual Life Res. 1993; 2: 51.
  • 23
    Smets EM,Garssen B,Bonke B,de Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39: 315325.
  • 24
    Smets EM,Garssen B,Cull A,de Haes JC. Application of the Multidimensional Fatigue Inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996; 73: 241245.
  • 25
    Zigmond AS,Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361370.
  • 26
    Newell S,Sanson-Fisher RW,Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002; 94: 558584.
  • 27
    Spiegel D,Bloom JR,Yalom I. Group support for patients with metastatic cancer. Arch Gen Psychiatry. 1981; 38 527533.
  • 28
    Redelmeier DA,Lorig K. Assessing the clinical importance of symptomatic improvements. Arch Intern Med. 1993; 153: 13371342.
  • 29
    Rabe-Hesketh S,Skrondal A,Pickles A. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J. 2002; 2: 121.
  • 30
    Altman DG. Practical Statistics for Medical Research. London, United Kingdom: Chapman & Hall; 1991.
  • 31
    Stone P,Richards M,A'Hern R,Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage. 2001; 22: 10071015.
  • 32
    Stone P,Richards M,A'Hern R,Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000; 11: 561567.
  • 33
    Okuyama T,Akechi T,Kugaya A, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer. 2000; 8: 215222.
  • 34
    Jacobsen PB,Weitzner MA. Fatigue and depression in cancer patients: conceptual and clinical issues. In: ArmesJ,KrishnasamyM,HigginsonIJ, eds. Fatigue in Cancer. Oxford, United Kingdom: Oxford University Press; 2004: 223241.